Reversing stomach lining changes to lower cancer risk
Part of Digestive system clinical trials.
This trial tests whether a treatment can reverse stomach lining changes called GIM that increase cancer risk. It's for people who have had a past H. pylori infection but no current stomach cancer, and whose GIM has certain high-risk features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with gastric intestinal metaplasia (GIM), a change in your stomach lining.
- Your GIM has at least one high-risk feature, like being widespread, a certain type (incomplete or mixed), or having a family history of stomach cancer.
- You have had H. pylori infection in the past, but you do not have it now.
- You are not currently being treated for active stomach cancer.
- You are not at high risk for bleeding (for example, due to blood thinners or a bleeding disorder) and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
This trial tests whether berberine, a natural plant compound, can help reverse precancerous changes in the stomach lining. If you have a certain type of stomach cell change (called gastric intestinal metaplasia) and do not have an H. pylori infection, this study might be an option.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This study tests if Weifuchun tablets can reverse precancerous changes called gastric intestinal metaplasia. If you have this condition and no H. pylori infection, you may qualify.
This trial tests whether a safe, older drug (pyrvinium) can reverse abnormal changes in the stomach lining that may lead to cancer. It might help people who have precancerous cells in their stomach to prevent them from becoming cancer.
This trial tests whether a personalized AI program can give you better health advice based on your stomach condition. It is for people who have gastric intestinal metaplasia (GIM) or have had H. pylori infection and are already scheduled for a gastroscopy.
Hear when a new Gastric Intestinal Metaplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.